Back To Her Biotech Roots: An Interview With Anna Protopapas
This article was originally published in Start Up
Executive Summary
After almost two decades at Millennium/Takeda, Anna Protopapas moves to tiny Mersana Therapeutics, which aims to power up oncology with its Fleximer drug conjugate platform.